TESTING THE EFFICIENCY-CAPM JOINT HYPOTHESIS IN THE BOVESPA

Market efficiency implies stock prices fully reflect all publicly available information instantaneously and, thus, no investment strategies can systematically earn abnormal returns. However, market efficiency per se is not testable. In order to analyze whether a stock market is efficient we have to test the joint hypothesis which refers fact that testing for market efficiency necessary involves asset pricing models. Then, we can compare real returns with expected returns predicted by a specific pricing model. In this context, the purpose of this study is to analyze whether the BOVESPA is an efficient market or, by contrast, it is possible to obtain abnormal returns employing the Capital Asset Pricing Model. To that end, we employ an intuitive trading rule based on purchasing exclusively those shares that are considered undervalued by the CAPM and compare it with the passive strategy of purchasing all shares that are members of the selective market index. Finally, our results are consistent with market efficiency as well as with the CAPM

Multi-analyte method for the quantification of bisphenol related compounds in canned food samples and exposure assessment of the Spanish adult population

Major types of internal can coatings used for food and beverages are made from synthetic polymers known as epoxy-based resins, mainly based on bisphenol A diglycidyl ether (BADGE). The migration of components from coatings to food is a concern for food safety. A multiresidue method was developed for the identification and quantification of six bisphenols, BADGE and its derivatives, and cyclo-di-BADGE in sixteen canned food samples based on HPLC-FLD. The method developed showed excellent validation data with an adequate linearity, low detection levels, good repeatability and acceptable recoveries. Confirmation of the obtained results was made by LC–MS/MS. The exposure of the adult population to these compounds through the consumption of canned food was assessed. In general, the results suggested a low dietary exposure to this type of compounds (0.003 to 0.985 μg/kg bw/day) with values lower than the established tolerable day intake (TDI). The highest mean concentration was observed for cyclo-di-BADGE in a sample of pickled musselsS

The Diboson Excess: Experimental Situation and Classification of Explanations; A Les Houches Pre-Proceeding

We examine the `diboson' excess at $\sim 2$ TeV seen by the LHC experiments in various channels. We provide a comparison of the excess significances as a function of the mass of the tentative resonance and give the signal cross sections needed to explain the excesses. We also present a survey of available theoretical explanations of the resonance, classified in three main approaches. Beyond that, we discuss methods to verify the anomaly, determining the major properties of the various surpluses and exploring how different models can be discriminated. Finally, we give a tabular summary of the numerous explanations, presenting their main phenomenological features.Comment: 37 pages, 9 Figures, 1 Tabl

Por D. Manuel Gamito Cascón, subrogado en el derecho de Don Fernando Gonzáleaz, difunto... con el Marqués de Campo Sagrado... sobre el precio de tanteo de sus reales contribuciones, pago de costas, y gastos de partido y corte, prueba y demás deducido en el pleyto

Sign.: A-H2 +. -- Hojas impresas por ambas carasCopia digital : Biblioteca de Asturias "Ramón Pérez de Ayala" : Biblioteca Pública Estatal de Oviedo, 201

i-DPs CGRA: An Interleaved-Datapaths Reconfigurable Accelerator for Embedded Bio-signal Processing

Smart edge sensors for bio-signal monitoring must support complex signal processing routines within an extremely small energy envelope. Coarse-Grained Reconfigurable Arrays (CGRAs) are good candidates for tackling these conflicting objectives because, thanks to their flexibility and high computational density, they can efficiently support the computational hot-spots characterizing bio-DSP applications. The Interleaved- Datapaths (i-DPs) CGRA presented in this paper further leverages the benefits of this architectural paradigm, focusing on ultralow energy operation. Its defining feature is the complex design of its computing cells, which, by embedding multiple i-DPs, allow a high ratio between computing and control logic, effectively speeding up computations, and resulting in a marginal impact on the required IC area. Interleaved datapaths increase the energy efficiency of up to 33 %, with respect to a single-DP alternative, when executing common kernels in the multi-lead ECG signal processing field

Making EHRs trustable: A quality analysis of EHR-derived datasets for COVID-19 research

One approach to verifying the quality of research data obtained from EHRs is auditing how complete and correct the data are in comparison with those collected by manual and controlled methods. This study analyzed data quality of an EHR-derived dataset for COVID-19 research, obtained during the pandemic at Hospital Universitario 12 de Octubre. Data were extracted from EHRs and a manually collected research database, and then transformed into the ISARIC-WHO COVID-19 CRF model. Subsequently, a data analysis was performed, comparing both sources through this convergence model. More concepts and records were obtained from EHRs, and PPV (95% CI) was above 85% in most sections. In future studies, a more detailed analysis of data quality will be carried out

Concordance of p16INK4a and E6*I mRNA among HPV-DNA-Positive Oropharyngeal, Laryngeal, and Oral Cavity Carcinomas from the ICO International Study

Simple Summary The utility of a diagnostic algorithm for the detection of HPV-driven oral cavity (OCC), oropharyngeal (OPC), and laryngeal (LC) carcinomas using HPV-DNA testing followed by p16(INK4a) immunohistochemistry, taking E6*I mRNA detection as the reference standard, was assessed in HPV-DNA-positive formalin-fixed paraffin-embedded samples from 29 countries. The concordance of p16(INK4a) and E6*I mRNA among 78, 257, and 51 HPV-DNA-positive OCC, OPC, and LC, respectively, was moderate to substantial in OCC and OPC but only fair in LC. A different p16(INK4a) expression pattern was observed in those cases HPV-DNA-positive for types other than HPV16, as compared to HPV16-positive cases. We concluded that the diagnostic algorithm of HPV-DNA testing followed by p16(INK4a) immunohistochemistry might be helpful in the diagnosis of HPV-driven OCC and OPC, but not LC. Our study provides new insights into the use HPV-DNA, p16(INK4a), and HPV-E6*I mRNA for diagnosing an HPV-driven head and neck carcinoma. Background: Tests or test algorithms for diagnosing HPV-driven oral cavity and laryngeal head and neck carcinomas (HNC) have not been yet validated, and the differences among oral cavity and laryngeal sites have not been comprehensively evaluated. We aimed to assess the utility of a diagnostic algorithm for the detection of HPV-driven oral cavity (OCC), oropharyngeal (OPC) and laryngeal (LC) carcinomas using HPV-DNA testing followed by p16(INK4a) immunohistochemistry, taking E6*I mRNA detection as the reference standard. Methods: Formalin-fixed paraffin-embedded OCC, OPC, and LC carcinomas were collected from pathology archives in 29 countries. All samples were subjected to histopathological evaluation, DNA quality control, and HPV-DNA detection. All HPV-DNA-positive samples (including 78 OCC, 257 OPC, and 51 LC out of 3680 HNC with valid HPV-DNA results) were also tested for p16(INK4a) immunohistochemistry and E6*I mRNA. Three different cutoffs of nuclear and cytoplasmic staining were evaluated for p16(INK4a): (a) >25%, (b) >50%, and (c) >= 70%. The concordance of p16(INK4a) and E6*I mRNA among HPV-DNA-positive OCC, OPC, and LC cases was assessed. Results: A total of 78 OCC, 257 OPC, and 51 LC were HPV-DNA-positive and further tested for p16(INK4a) and E6*I mRNA. The percentage of concordance between p16(INK4a) (cutoff >= 70%) and E6*I mRNA among HPV-DNA-positive OCC, OPC, and LC cases was 79.5% (95% CI 69.9-89.1%), 82.1% (95% CI 77.2-87.0%), and 56.9% (95% CI 42.3-71.4%), respectively. A p16(INK4a) cutoff of >50% improved the concordance although the improvement was not statistically significant. For most anatomical locations and p16(INK4a) cutoffs, the percentage of discordant cases was higher for HPV16- than HPV-non16-positive cases. Conclusions: The diagnostic algorithm of HPV-DNA testing followed by p16(INK4a) immunohistochemistry might be helpful in the diagnosis of HPV-driven OCC and OPC, but not LC. A different p16(INK4a) expression pattern was observed in those cases HPV-DNA-positive for types other than HPV16, as compared to HPV16-positive cases. Our study provides new insights into the use HPV-DNA, p16(INK4a), and HPV-E6*I mRNA for diagnosing an HPV-driven HNC, including the optimal HPV test or p16(INK4a) cutoffs to be used. More studies are warranted to clarify the role of p16(INK4a) and HPV status in both OPC and non-OPC HNC